5-Methyladenosine (m5C) is a type of epigenetic modification involved in the progression of
various cancers. To investigate the role of m5C-related long non-coding RNAs (lncRNAs) in …

Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …

Abstract Background N6-methyladenosine (m6A) is a common modification and plays an
important role in various biological processes, but m6A-related lncRNA functions in …

Background Hepatocellular carcinoma (HCC) is the most prevalent pathological type of liver
cancer worldwide with high mortality and poor prognosis. N6-methyladenosine (m6A) can …

Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …

Despite great advances in the treatment of liver hepatocellular carcinoma (LIHC), such as
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …

We aimed to illustrate the influence of N6-methyladenosine (m6A) long non-coding RNAs
(lncRNAs) and immune cell infiltration in hepatocellular carcinoma (HCC). The relationship …

Accumulating studies have demonstrated critical roles of N6-methyladenosine (m6A)
modification and long noncoding RNAs (lncRNAs) in the biological processes leading to …

Background N7-methylguanosine (m7G) is one of the most common RNA posttranscriptional
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …

RNA modification serves as a kind of posttranscriptional modification. Besides N6-
methyladenosine (m6A), 5-methylcytosine (m5C) is also an important RNA modification …